How to buy Mediclinic International (MDC) shares

Learn how to easily invest in Mediclinic International shares.

Mediclinic International plc
LSE: MDC - GBX
MEDICAL CARE FACILITIES
p335.00
- p1.80 ( - 0.53%)

Mediclinic International plc (MDC) is a leading medical care facilities business based in the UK. On 14 October Mediclinic International shares leapt 12.25% to a closing position of 346.4p. Over the last 12 months, Mediclinic International's share price has risen by 8.98% from 307.4p. Mediclinic International is listed on the London Stock Exchange (LSE) and employs 30,470 staff. All prices are listed in pence sterling.

How to buy shares in Mediclinic International

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: MDC in this case.
  5. Research Mediclinic International shares. The platform should provide the latest information available.
  6. Buy your Mediclinic International shares. It's that simple.
The whole process can take as little as 15 minutes.

How has coronavirus impacted Mediclinic International's share price?

Since the stock market crash that started in February 2020, Mediclinic International's share price has had significant negative movement.

Its last market close was 336.8p, which is 13.66% down on its pre-crash value of 390.1p and 35.37% up on the lowest point reached during the March 2020 crash when the shares fell as low as 248.8p.

If you had bought £1,000 worth of Mediclinic International shares at the start of February 2020, those shares would have been worth £724.75 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth £900.06.

Mediclinic International share price (LSE:MDC)

Use our graph to track the performance of MDC stocks over time.

Mediclinic International shares at a glance

Information last updated 2021-10-26.
Open337.4p
High340p
Low332.8p
Close335p
Previous close336.8p
Change-1.8p
Change %-0.5344%
Volume656,230
Information last updated 2021-10-24.
52-week range266.4p - 349p
50-day moving average316.6629p
200-day moving average306.9063p
Wall St. target price361.64p
PE ratio35.8913
Dividend yield0p (0%)
Earnings per share (TTM)9.2p
Promoted
eToro Free Stocks

Invest in Mediclinic International shares with 0% commission

Other fees apply. Your capital is at risk.

  • Unlimited trades, with no dealing charges or management fees
  • Pay no stamp duty on UK shares (saving 0.5%)
  • Create an account today in a few minutes
Capital at risk

Fees for buying 100x Mediclinic International shares with popular platforms

Share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform Platform fee Min. initial deposit Trading fee estimate
Freetrade logo £0 No minimum £0.00
£335.00 total
Capital at risk
eToro Free Stocks logo £0 $50 £0.00
£335.00 total
Capital at risk
Fineco logo £0 No minimum £0.00
£335.00 total
Capital at risk
Degiro Share Dealing logo £0 £0.01 £1.80
£336.80 total
Capital at risk
Hargreaves Lansdown Fund and Share Account logo £0 £1 £11.95
£346.95 total
Capital at risk
interactive investor Trading Account logo £9.99 per month No minimum £7.99
£342.99 total
Capital at risk
Halifax Share Dealing Account logo £36 per year £20 £9.50
£344.50 total
Capital at risk

Full comparison of share dealing platforms

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is it a good time to buy Mediclinic International stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Is Mediclinic International under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value.

P/E ratio

Mediclinic International's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 36x. In other words, Mediclinic International shares trade at around 36x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

EBITDA

Mediclinic International's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £349 million.

The EBITDA is a measure of a Mediclinic International's overall financial performance and is widely used to measure a its profitability.

Financials

Revenue TTM £3 billion
Operating margin TTM 6.95%
Gross profit TTM £620 million
Return on assets TTM 1.91%
Return on equity TTM 2.65%
Profit margin 2.27%
Book value 3.864p
Market capitalisation £2.4 billion

TTM: trailing 12 months

Environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Mediclinic International.

Total ESG risk score

Mediclinic International's total ESG risk: 22.08

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Mediclinic International's overall score of 22.08 (as at 12/31/2018) is pretty good – landing it in it in the 34th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Mediclinic International is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Environmental score

Mediclinic International's environmental score: 0.69/100

Mediclinic International's environmental score of 0.69 puts it squarely in the 3rd percentile of companies rated in the same sector. This could suggest that Mediclinic International is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Social score

Mediclinic International's social score: 11.99/100

Mediclinic International's social score of 11.99 puts it squarely in the 3rd percentile of companies rated in the same sector. This could suggest that Mediclinic International is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Governance score

Mediclinic International's governance score: 8.4/100

Mediclinic International's governance score puts it squarely in the 3rd percentile of companies rated in the same sector. That could suggest that Mediclinic International is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Controversy score

Mediclinic International's controversy score: 2/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. A high-profile company, Mediclinic International scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Mediclinic International has, for the most part, managed to keep its nose clean.

Environmental, social, and governance (ESG) summary

Mediclinic International plc was last rated for ESG on: 2019-01-01.

Total ESG score 22.08
Total ESG percentile 33.76
Environmental score 0.69
Environmental score percentile 3
Social score 11.99
Social score percentile 3
Governance score 8.4
Governance score percentile 3
Level of controversy 2

Mediclinic International share dividends

3.0%

Forward annual dividend yield: 2.96% of stock value

The latest dividend was paid out to all shareholders who bought their shares by 4 December 2019 (the "ex-dividend date").

Mediclinic International dividend history

Dividend Type Ex-dividend date Payment date
£0.032 Interim 05/12/2019 17/12/2019
£0.047 Final 13/06/2019 29/07/2019
£0.032 Interim 06/12/2018 18/12/2018
£0.047 Final 14/06/2018 30/07/2018
£0.032 Interim 07/12/2017 18/12/2017
£0.047 Final 22/06/2017 31/07/2017
£0.032 Interim 24/11/2016 12/12/2016
£0.0524 Final 16/06/2016 25/07/2016
£0.041 Interim 03/09/2015 05/10/2015
£0.09 Final 16/04/2015 15/05/2015
£0.037 Interim 10/09/2014 10/10/2014
£0.09 Final 12/03/2014 11/04/2014

Share price volatility

Over the last 12 months, Mediclinic International's shares have ranged in value from as little as 266.4p up to 349p. A popular way to gauge a stock's volatility is its "beta".

MDC.LSE volatility(beta: 0.74)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Mediclinic International's is 0.7445. This would suggest that Mediclinic International's shares are less volatile than average (for this exchange).

Win £500 to get your trading started

Subscribe to trending stock alerts for a chance to win

By submitting, you agree to the Finder Privacy and Cookies Policy and Terms of Use

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site